Heart repair by cardiac reprogramming.
Nam, Young-Jae, Kunhua Song, and Eric N Olson. 2013. “Heart Repair by Cardiac Reprogramming.”. Nature Medicine 19 (4): 413-5.
Search
Search results
755 results found
CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.
Backs, Johannes, Kunhua Song, Svetlana Bezprozvannaya, Shurong Chang, and Eric N Olson. 2006. “CaM Kinase II Selectively Signals to Histone Deacetylase 4 During Cardiomyocyte Hypertrophy.”. The Journal of Clinical Investigation 116 (7): 1853-64.
Amplification and Cloning by Long RT-PCR of Full-length Genome of Larger Segment of Chicken Infectious Bursal Disease Virus.
Huang, Yao-Wei, Lian Yu, Hong-Mei Ding, Jian-Rong Li, and Kun-Hua Song. 2001. “Amplification and Cloning by Long RT-PCR of Full-Length Genome of Larger Segment of Chicken Infectious Bursal Disease Virus.”. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao Acta Biochimica et Biophysica Sinica 33 (3): 355-59.
The molecular mechanism of sialic acid transport mediated by Sialin.
Hu, Wenxin, Congwu Chi, Kunhua Song, and Hongjin Zheng. 2023. “The Molecular Mechanism of Sialic Acid Transport Mediated by Sialin.”. Science Advances 9 (3): eade8346.
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.
Comella, CL, J Jankovic, RA Hauser, AT Patel, MD Banach, E Ehler, D Vitarella, RG Rubio, and TM Gross. 2024. “Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial.”. Neurology. 2024 Feb 27;102(4):e208091. Doi: 10.1212/WNL.0000000000208091. Epub 2024 Jan 31. PMID: 38295339.
Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.
Frank, S, KE Anderson, HH Fernandez, RA Hauser, DO Claassen, D Stamler, SA Factor, et al. 2024. “Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated With Huntington Disease.”. Neurol Ther. 2024 Jun;13(3):655-675. Doi: 10.1007/S40120-024-00600-1. Epub 2024 Apr 1.PMID: 38557959.
Effects of triheptanoin (UX007) in patients with long-chain fatty acid oxidation disorders: Results from an open-label, long-term extension study. Journal of inherited metabolic disease, 44(1), 253–263. https://doi.org/10.1002/jimd.12313
Prolonged clonazepam-induced withdrawal symptoms in an NAT2 ultraslow acetylator. Pharmacogenomics, 20(2), 69–73. https://doi.org/10.2217/pgs-2018-0145
“Prolonged Clonazepam-Induced Withdrawal Symptoms in an NAT2 Ultraslow Acetylator. Pharmacogenomics, 20(2), 69–73. Https://Doi.org/10.2217/Pgs-2018-0145”. 2019. Journal of Iaculis Nisl Facilisis Malesuada Maecenas.
Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD). Journal of inherited metabolic disease, 42(1), 169–177.
Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia. 2022 Oct 20;13:846126. doi: 10.3389/fneur.2022.846126. eCollection 2022. PMID: 36341088
Pahwa, R, S Fox, RA Hauser, S Isaacson, J Lytle, R Johnson, L Llorens, AE Formella, and CM Tanner. 2022. “Clinically Important Change on the Unified Dyskinesia Rating Scale Among Patients With Parkinson’s Disease Experiencing Dyskinesia. 2022 Oct 20;13:846126. Doi: 10.3389/Fneur.2022.846126. ECollection 2022. PMID: 36341088”. Front Neurol.